|
|
|
DECEMBER 2006 Welcome to the last full edition of the Friends of Cancer Research newsletter - a special year-end edition will follow later this month. As Friends celebrates its 10th Anniversary, we are working to improve the delivery, content, and style of our news updates to you. Please email us with any comments or suggestions at info@focr.org.
C ongress to Pass Continuing Resolution Through Early Next Year-- NIH Reauthorization Bill & FDA Commissioner Confirmation Still On TableWith the November 7 elections leading to a shift in power on Capitol Hill, the Republican leadership of the House and Senate plan to postpone final action on the remaining fiscal year (FY) 2007 appropriations bills until next year, forcing the Democratic-controlled 110th Congress to deal with the issue. After the election, Congress reconvened for one week and approved a continuing resolution (CR) that funds the remaining ten annual appropriations bills through December 8. Several sources are reporting that when the House and Senate reconvene on Tuesday, December 5, they will work to approve a long-term CR that funds those ten spending bills through early next year, possibly March. This CR is expected to continue to use the lower number of the House-passed FY 2007, Senate-passed FY 2007, or FY 2006 enacted level for its funding basis. If Congress moves forward with approving a long-term CR, it is unclear how long the House and Senate would remain in session in December. Some pundits are speculating that the House could pass the CR and adjourn for the year next week. In the Senate, the nomination of Robert Gates as Secretary of the Department of Defense is awaiting action, so the Senate could stay in session through the week of December 11 to confirm him. Such a short December session would leave little time for the Senate to deal with two important issues—the reauthorization of the National Institutes of Health (NIH) and the confirmation of Andrew C. von Eschenbach, MD, as commissioner of the Food and Drug Administration. In late September 2006, the House passed the National Institutes of Health Reform Act of 2006 (HR 6164) that reauthorizes NIH through FY 2009. Up to this point, the Senate has not addressed reauthorizing NIH but Senate Health, Education, Labor, and Pensions Committee Chair Mike Enzi (R-WY) has been working behind closed doors over the last few weeks on producing the Senate’s version of this bill. It is unclear whether there will be enough time during the December session for the Senate to tackle this issue. For Dr. von Eschenbach’s nomination, it has been reported that Senate Finance Committee Chair Chuck Grassley (R-IA) is the third Senator to have a hold on the nomination, although Chairman Enzi has vowed to work to lift the holds to allow for confirmation before Congress adjourns for the year. If you have questions, or need more information, please contact FOCR Director of Government Affairs Jeff Coughlin at (703) 302-1543 or jcoughlin@focr.org.
Senate Committee Holds Hearing on Drug Safety On November 16th the Senate Health, Education, Labor and Pension (HELP) committee held a hearing entitled "Building a 21st Century FDA: Proposals to Improve Drug Safety and Innovation". The primary focus of the hearing was the recently released Institutes of Medicine (IOM) report on drug safety. Shelia Burke, chair of the IOM committee on the assessment of the U.S. drug safety system, outlined the committee’s findings. On September 26th, the IOM released a report containing a number of recommendations aimed at enhancing drug review, safety surveillance and the functioning of the Center for Drug Evaluation and Review at FDA. The committee also made recommendations to increase overall resource for the agency and improve public communication. Also of discussion at the hearing was “The Enhancing Drug Safety and Innovation Act of 2006.” This legislation was introduced this fall by HELP committee chair Senator Michael Enzi (R-WY) and ranking member Senator Edward Kennedy (D-MA). Providing input was a panel of representative experts from consumer groups, industry, and patient groups. While some panelists offered different suggestions of improvements that FDA could make, all of the panelists agreed that in order for the FDA to continue as the gold-standard agency it would require increased resources from congressional appropriations. During the upcoming 110th Congress it is likely that drug safety and FDA will receive a great deal of attention. Along with previously introduced legislation, Congress will look to renew the Prescription Drug User Fee Act, which provides vital resources for FDA product review. Joining the drug safety debate next year as new members of the Senate HELP committee are Senator Barack Obama (D-IL), and Senators-elect Sherrod Brown (D-OH) and Bernie Sanders (I-VT).
Friends Celebrates Tenth Anniversary with special Benefit Evening at The Four Seasons Hotel
As part of its anniversary celebration, Friends of Cancer Research hosted a special Tenth Anniversary Benefit at the Four Seasons Hotel on November 15th. The evening began with a Friends video celebrating a decade of achievement and featuring some of Friends most prominent friends reminiscing about how the organization has played a role in the cancer community over the last ten years. The video, which can be viewed on the Friends website, includes remarks from former CEO of Paramount Pictures Sherry Lansing, AACI President Dr. Shelly Earp, NIH Director Dr. Elias Zerhouni, former HHS Secretary Tommy Thompson, FDA Acting Commissioner Dr. Andrew on Eschenbach, former Congressman and Research!America chair The Honorable John Edward Porter, and Entertainment Industry Foundation President & CEO Lisa Paulsen. View the video.
In between a unique four-course tasting menu, Master of Ceremonies Sam Donaldson led the program of award presentations to prominent members of Congress, the Administration, and the entertainment industry who have demonstrated steadfast leadership and support in their work for cancer research.
The evening’s awards wrapped up with a Friends would like to thank again all of the sponsors and individuals who made the event such a success. For a full listing of sponsors (as of 11.15.06) please view our sponsorship slideshow.
Password = 4099
You may also purchase pictures directly from the site. Questions or
problems, please call (703)302-1503.
2231 Crystal Drive Full staff directory: www.focr.org/move.html
|
||||||||||||||||||
To subscribe or unsubscribe email info@focr.org with subject "Newsletter" and your contact information.